Actively Recruiting
A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures
Led by Mayo Clinic · Updated on 2025-05-13
120
Participants Needed
1
Research Sites
178 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research is being done to find out whether intravenous magnesium is effective in the treatment of bladder spasms after urologic surgery.
CONDITIONS
Official Title
A Study of Magnesium and Bladder Spasms Following Ambulatory Urologic Procedures
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be undergoing a bladder invasive procedure with or without planned urinary catheter on Mayo Clinic Gonda 7 Outpatient Procedure Center.
You will not qualify if you...
- Unable to grant informed consent or comply with study procedures.
- Allergy or known sensitivity to magnesium or Renacidin.
- Expected or high risk of bladder extravasation.
- Ongoing atrial fibrillation prior to surgery.
- Undergoing emergency surgery.
- Pregnant.
- Known hypermagnesemia.
- Neuromuscular weakness (e.g., Myasthenia gravis) due to magnesium's muscle weakening effect.
- Myocardial compromise or cardiac conduction defects because of magnesium's anti-inotropic effects.
- Renal insufficiency with glomerular filtration rate less than 30.
- Concomitant use of a calcium channel blocker due to possible synergistic suppression of muscular contractility.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Minnesota
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
T
Tami Krpata
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here